NOCITA® (bupivacaine liposome injectable suspension) is an amide local anesthetic in an encapsulated liposomal formulation that was developed with the goal of providing a longer duration of post-operative analgesia compared with its nonliposomal counterpart bupivacaine HCl or other local anesthetic solutions. The use of NOCITA contributes to a modern multimodal analgesia plan. Its extended duration of action assists in preventing analgesia gaps during the first 72 hours following CCL surgery in dogs and onychectomy in cats. NOCITA provides a bridge between an in-hospital analgesia plan and postsurgical pain relief in the home environment. Additionally, NOCITA is administered at the time of closure by the surgeon in dogs and prior to onychectomy in cats and does not require repeat or continuous administration post-operatively, saving valuable technician time.
Please see full Prescribing Information for more detail.